10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Sinovac Biotech Ltd (SVA)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,718,735 | $184,466,170 | 4.33% | |
| 2. | Vivo Capital Albert Cha And Frank Kung | 5,903,000 | $38,192,410 | 3.07% | |
| 3. | Renaissance Technologies Jim Simons | 1,312,520 | $0 | 0% | |
| 4. | Navellier & Associates Louis Navellier | 13,568 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,876 | $109,188 | 0% | |
| 2. | 16,430 | $106,302 | 0% | |
| 3. | 9,144 | $59,161 | 0% | |
| 4. | 2,222 | $14,376 | 0% | |
| 5. | 315,586 | $2,042 | 0.52% |
News See All
Here is What Hedge Funds Think About Sinovac Biotech Ltd. (SVA)
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Is Sinovac Biotech Ltd. (SVA) A Good Stock to Buy?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Here is What Hedge Funds Think About Sinovac Biotech Ltd. (SVA)
The government requires hedge funds and wealthy investors with over a certain portfolio size to file a report that shows their positions at the end of every quarter.
Hedge Funds Are Betting On Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (NASDAQ:ANIK) was in 7 hedge funds' portfolio at the end of the first quarter of 2013.
This Week in Biotech: Navidea Biopharmaceuticals Inc (NAVB), Sinovac Biotech Ltd. (SVA) and More
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Whoa! These 3 Stocks Didn't Deserve Their Gains: Sinovac Biotech Ltd. (SVA), Joe's Jeans Inc (JOEZ), Bazaarvoice Inc (BV)
The Dow Jones Industrial Average is turning this winning streak into a marathon.